Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 200045

Expand all

AMTURNIDE (ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE)
EQ 150MG BASE;EQ 5MG BASE;12.5MG Marketing Status: Discontinued

Active Ingredient: ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE
Proprietary Name: AMTURNIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 150MG BASE;EQ 5MG BASE;12.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N200045
Product Number: 001
Approval Date: Dec 21, 2010
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

AMTURNIDE (ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE)
EQ 300MG BASE;EQ 5MG BASE;12.5MG Marketing Status: Discontinued

Active Ingredient: ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE
Proprietary Name: AMTURNIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 300MG BASE;EQ 5MG BASE;12.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N200045
Product Number: 002
Approval Date: Dec 21, 2010
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

AMTURNIDE (ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE)
EQ 300MG BASE;EQ 5MG BASE;25MG Marketing Status: Discontinued

Active Ingredient: ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE
Proprietary Name: AMTURNIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 300MG BASE;EQ 5MG BASE;25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N200045
Product Number: 003
Approval Date: Dec 21, 2010
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

AMTURNIDE (ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE)
EQ 300MG BASE;EQ 10MG BASE;12.5MG Marketing Status: Discontinued

Active Ingredient: ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE
Proprietary Name: AMTURNIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 300MG BASE;EQ 10MG BASE;12.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N200045
Product Number: 004
Approval Date: Dec 21, 2010
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

AMTURNIDE (ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE)
EQ 300MG BASE;EQ 10MG BASE;25MG Marketing Status: Discontinued

Active Ingredient: ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE
Proprietary Name: AMTURNIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 300MG BASE;EQ 10MG BASE;25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N200045
Product Number: 005
Approval Date: Dec 21, 2010
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English